These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1791586)

  • 41. Use of a monophasic, low-dose oral contraceptive in relation to mental functioning.
    Deijen JB; Duyn KJ; Jansen WA; Klitsie JW
    Contraception; 1992 Oct; 46(4):359-67. PubMed ID: 1486774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral contraception and cyclic changes in premenstrual and menstrual experiences.
    Abraham S; Luscombe G; Soo I
    J Psychosom Obstet Gynaecol; 2003 Sep; 24(3):185-93. PubMed ID: 14584305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of oral contraceptives on daily self-ratings of positive and negative affect.
    Oinonen KA; Mazmanian D
    J Psychosom Res; 2001 Nov; 51(5):647-58. PubMed ID: 11728505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
    Bancroft J; Rennie D
    J Psychosom Res; 1993; 37(2):195-202. PubMed ID: 8463994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in macronutrient selections in users and nonusers of an oral contraceptive.
    Eck LH; Bennett AG; Egan BM; Ray JW; Mitchell CO; Smith MA; Klesges RC
    Am J Clin Nutr; 1997 Feb; 65(2):419-24. PubMed ID: 9022525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. University students' subjective experiences of oral contraceptive use.
    Condon JT; Need JA; Fitzsimmons D; Lucy S
    J Psychosom Obstet Gynaecol; 1995 Mar; 16(1):37-43. PubMed ID: 7787956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives.
    Ekenros L; Bäckström T; Hirschberg AL; Fridén C
    Gynecol Endocrinol; 2019 May; 35(5):422-426. PubMed ID: 30668208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
    Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
    Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron stores in users of oral contraceptive agents.
    Frassinelli-Gunderson EP; Margen S; Brown JR
    Am J Clin Nutr; 1985 Apr; 41(4):703-12. PubMed ID: 3984924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.